Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Twenty Five Year Follow-up For Breast Cancer Incidence And Mortality Of The Canadian National Breast Screening Study: Randomised Screening Trial

A. Miller, C. Wall, C. Baines, P. Sun, T. To, S. Narod
Published 2014 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Objective To compare breast cancer incidence and mortality up to 25 years in women aged 40-59 who did or did not undergo mammography screening. Design Follow-up of randomised screening trial by centre coordinators, the study’s central office, and linkage to cancer registries and vital statistics databases. Setting 15 screening centres in six Canadian provinces,1980-85 (Nova Scotia, Quebec, Ontario, Manitoba, Alberta, and British Columbia). Participants 89 835 women, aged 40-59, randomly assigned to mammography (five annual mammography screens) or control (no mammography). Interventions Women aged 40-49 in the mammography arm and all women aged 50-59 in both arms received annual physical breast examinations. Women aged 40-49 in the control arm received a single examination followed by usual care in the community. Main outcome measure Deaths from breast cancer. Results During the five year screening period, 666 invasive breast cancers were diagnosed in the mammography arm (n=44 925 participants) and 524 in the controls (n=44 910), and of these, 180 women in the mammography arm and 171 women in the control arm died of breast cancer during the 25 year follow-up period. The overall hazard ratio for death from breast cancer diagnosed during the screening period associated with mammography was 1.05 (95% confidence interval 0.85 to 1.30). The findings for women aged 40-49 and 50-59 were almost identical. During the entire study period, 3250 women in the mammography arm and 3133 in the control arm had a diagnosis of breast cancer, and 500 and 505, respectively, died of breast cancer. Thus the cumulative mortality from breast cancer was similar between women in the mammography arm and in the control arm (hazard ratio 0.99, 95% confidence interval 0.88 to 1.12). After 15 years of follow-up a residual excess of 106 cancers was observed in the mammography arm, attributable to over-diagnosis. Conclusion Annual mammography in women aged 40-59 does not reduce mortality from breast cancer beyond that of physical examination or usual care when adjuvant therapy for breast cancer is freely available. Overall, 22% (106/484) of screen detected invasive breast cancers were over-diagnosed, representing one over-diagnosed breast cancer for every 424 women who received mammography screening in the trial.
This paper references
10.1093/JNCI/92.18.1490
Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years.
A. Miller (2000)
Toomuchmammography [ editorial ]
KalagerM
Report of the "ad hoc" committee on mammography
J L Leger (1974)
10.7326/0003-4819-137-5_Part_1-200209030-00005
The Canadian National Breast Screening Study-1: Breast Cancer Mortality after 11 to 16 Years of Follow-up: A Randomized Screening Trial of Mammography in Women Age 40 to 49 Years
A. Miller (2002)
10.1136/bmj.b1425
Overdiagnosis and mammography screening
H. Welch (2009)
10.1056/NEJMoa1206809
Effect of three decades of screening mammography on breast-cancer incidence.
A. Bleyer (2012)
10.1093/JJCO/29.12.608
Primary and adjuvant therapy, prognostic factors and survival in 1053 breast cancers diagnosed in a trial of mammography screening.
L. Tabár (1999)
10.1136/bmj.38764.572569.7C
Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study.
Sophia Zackrisson (2006)
Deaths from breast cancers detected in years 1-5 (screening period)*
10.1093/aje/kwu227
Re: "Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial".
N. Weiss (2014)
Evidence on screening for breast
S Shapiro
Breast cancer screening with mammography : overview of Swedish randomized trials
FE Alexander (1993)
Canadian National Breast Screening Study.
H. Burhenne (1993)
Operational procedures and input data dictionary. Version 6. Public Health Agency of Canada
(2012)
Report of the "ad hoc" committee on mammography rapport du comite "ad hoc" sur la mammographie.
J. Léger (1974)
10.1172/JCI45710
The emperor of all maladies: A biography of cancer
S. Riddell (2011)
10.1016/S1470-2045(11)70250-9
Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
Per-Henrik Zahl (2011)
10.1056/NEJMp1401875
Abolishing mammography screening programs? A view from the Swiss Medical Board.
N. Biller-Andorno (2014)
Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
A. Miller (1992)
10.1186/bcr1314
Overdiagnosis and overtreatment of breast cancer: Overdiagnosis in randomised controlled trials of breast cancer screening
S. Moss (2005)
10.1093/jnci/62.3.647
Report of the Working Group to Review the National Cancer Institute-American Cancer Society Breast Cancer Detection Demonstration Projects.
(1979)
10.1093/JNCI/69.2.349
Ten- to fourteen-year effect of screening on breast cancer mortality.
S. Shapiro (1982)
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
(2014)
10.1148/radiol.11110469
Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades.
L. Tabár (2011)
10.1016/S0140-6736(05)61736-9
On being the right size: a reappraisal of mammography trials in Canada and Sweden
S. Narod (1997)
10.1002/1097-0142(197706)39:6<2772::AID-CNCR2820390665>3.0.CO;2-K
Evidence on screening for breast cancer from a randomized trial
S. Shapiro (1977)
10.1007/978-94-007-0753-5_103411
A Randomized Trial
S. V. Desai (2013)
10.1007/s10552-011-9867-8
Why mammography screening has not lived up to expectations from the randomised trials
P. Gøtzsche (2011)
10.5214/346
The Emperor of all Maladies: A Biography of Cancer
Himshikha Bhutani (2011)
10.1097/01.ede.0000181313.61948.76
Analysis of Mortality Data From Cancer Screening Studies: Looking in the Right Window
J. Hanley (2005)
Over-diagnosis in randomised controlled trials of breast cancer screening
S Moss (2005)
10.1001/JAMA.1971.03180240027005
Periodic breast cancer screening in reducing mortality from breast cancer.
S. Shapiro (1971)
Audit procedures in the National Breast Screening Study: mammography interpretation.
C. Baines (1986)
10.1002/1097-0142(19950215)75:4<997::AID-CNCR2820750415>3.0.CO;2-M
The excess of patients with advanced breast cancer in young women screened with mammography in the Canadian National Breast Screening Study
R. Tarone (1995)
10.3747/co.19.1043
Tumour size predicts long-term survival among women with lymph node-positive breast cancer.
S. Narod (2012)
Re : “ Twenty fi ve year follow - up for breast cancer incidence and mortality of the Canadian National Breast Screening Study : randomised screening trial ” [ letter ]
NS Weiss (2014)
Over-diagnosis and mammography screening [editorial
HG Welch (2009)
10.1002/ijc.25081
Conundrums in screening for cancer
A. Miller (2010)
10.2214/AJR.155.4.2119103
Canadian National Breast Screening Study: assessment of technical quality by external review.
C. Baines (1990)
10.1177/074823378900500605
A Study of Mortality in Workers Engaged in the Mining, Smelting, and Refining of Nickel: I: Methodology and Mortality by Major Cause Groups
R. S. Roberts (1989)
10.1136/bmj.38764.572569.7C
Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study
S. Zackrisson (2006)
Conundrums in screening for cancer. Mini review
A B Miller (2010)
Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
A. Miller (1992)



This paper is referenced by
10.1007/978-1-4939-1726-6_4
Abnormal Screening Mammogram
A. Grigorian (2015)
10.1007/s11606-015-3481-5
Medical Debates and Medical Reversal
A. Cifu (2015)
10.1093/jnci/djv345
Recognizing the Limitations of Cancer Overdiagnosis Studies: A First Step Towards Overcoming Them.
Ruth Etzioni (2016)
10.1177/2054270416649283
No difference found in time to publication by statistical significance of trial results: a methodological review
L. Jefferson (2016)
10.1016/J.BBE.2017.10.005
Contralateral asymmetry for breast cancer detection: A CADx approach
J. M. Celaya-Padilla (2018)
10.1093/jnci/djv078
Breast cancer prevention in the era of precision medicine.
S. Narod (2015)
10.3348/JKSR.2017.76.1.30
Effectiveness of Mammography Boot Camp for Radiology Residents
K. W. Kim (2017)
10.1109/ACCESS.2019.2941543
Accurate Prediction of Neoadjuvant Chemotherapy Pathological Complete Remission (pCR) for the Four Sub-Types of Breast Cancer
Xin Feng (2019)
10.6061/clinics/2019/e1573
Ethical issues surrounding breast cancer screening in Brazil
Rodrigo Gonçalves (2019)
10.1007/978-981-10-3147-2_12
Dynamic Angiothermography (DATG)
F. Casali (2017)
10.1136/BMJEBM-2018-111070.81
81 The evaluation of a breast cancer screening decision aid in the community setting
Kimberly Cuetara Gibbons (2018)
10.1016/j.jacr.2017.09.020
What Do Patients Want to Know? Questions and Concerns Regarding Mammography Expressed Through Social Media.
Abbas M Charlie (2018)
10.1186/s13058-015-0525-z
Benefits and harms of mammography screening
M. Løberg (2015)
10.1002/ijc.30754
The effect of population‐based mammography screening in Dutch municipalities on breast cancer mortality: 20 years of follow‐up
V. Sankatsing (2017)
10.1136/bmj.j5625
Breast cancer screening
M. Kalager (2017)
What’s Involved with Wanting to Be Involved? Comparing Expectations for Public Engagement in Health Policy across Research and Care Contexts
M. Ahuja (2017)
10.17269/s41997-020-00305-6
The incidence of breast cancer in Canada 1971–2015: trends in screening-eligible and young-onset age groups
E. Heer (2020)
10.1016/j.healthpol.2018.09.013
'I just want to be able to make a choice': Results from citizen deliberations about mammography screening in Ontario, Canada.
J. Abelson (2018)
10.1097/MD.0000000000005684
Clarifying the debate on population-based screening for breast cancer with mammography
T. Chen (2017)
10.2214/AJR.14.12881
Supporting informed choice before screening mammography is the only ethical option.
J. Keen (2014)
10.1089/JWH.2014.4860
Moving Beyond the Breast Cancer Screening Debate
EssermanLaura (2014)
editorial Breast Cancer Prevention in the Era of Precision Medicine
Steven A. Narod (2015)
10.1007/s15006-014-2683-9
Kein Einfluss auf die Mortalität
Urban Vogel (2014)
10.14279/DEPOSITONCE-10552
Development of model observers for quantitative assessment of mammography image quality
T. Kretz (2020)
10.1201/B19421-12
Efficiency and Variance Reduction
J. J. Caro (2015)
10.1109/TVCG.2015.2467758
Improving Bayesian Reasoning: The Effects of Phrasing, Visualization, and Spatial Ability
A. Ottley (2016)
10.3747/co.23.2881
Is clinical breast examination important for breast cancer detection?
L. Provencher (2016)
10.1136/bmjopen-2016-013770
Protocol for a scoping review of post-trial extensions of randomised controlled trials using individually linked administrative and registry data
T. Fitzpatrick (2017)
10.1590/S0080-623420160000100002
Rastreamento oportunístico do câncer de mama desenvolvido por enfermeiros da Atenção Primária à Saúde
D. Moraes (2016)
Improving the sensitivity of radar-based breast imaging algorithms in diverse patient populations
Declan O’Loughlin (2018)
Glandular tissue pattern analysis through multimodal mri-mammography registration
Eloy García Marcos (2018)
10.1377/hlthaff.2014.1087
National expenditure for false-positive mammograms and breast cancer overdiagnoses estimated at $4 billion a year.
Mei-Sing Ong (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar